Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Arm, FIH Study to Evaluate the Safety and Feasibility of the CAPTIS Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR)

NCT04659538 is registered in ClinicalTrials.gov with Filterlex Medical Ltd. as lead sponsor.

NCT NCT04659538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Arm, FIH Study to Evaluate the Safety and Feasibility of the CAPTIS Device in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR)
Lead sponsor
Filterlex Medical Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 24, 2020
Completion date
May 3, 2022
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve replacement